Identification of Genetic Factors Determining Disease Course in the New Type of Coronavirus Infection, COVID-19
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )
- Status
- TERMINATED
- Phase
- PHASE2
Cardiovascular Risk Factors and Severe COVID-19. A Nationwide Registry-based Case-Control Study
- Status
- UNKNOWN
- Phase
- N/A
COVID-19 Antibodies Among Healthcare Workers
- Status
- COMPLETED
- Phase
- N/A
Effectiveness and Safety of Convalescent Plasma in Patients With High-risk COVID-19
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Clinical Trial for Azvudine in the Treatment of Novel Coronavirus Pneumonia (COVID-19）
- Status
- UNKNOWN
- Phase
- NA
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19
- Status
- TERMINATED
- Phase
- PHASE3
A Phase 2 Trial of Infliximab in Coronavirus Disease 2019 (COVID-19).
- Status
- COMPLETED
- Phase
- PHASE2
A Multi-center,Randomized,Double-blind,Placebo-controlled,Phase 3 Study Evaluating Favipiravir in Treatment of COVID19
- Status
- UNKNOWN
- Phase
- PHASE3
Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
COVID-19 Lessons Learned: the Outcome of TOMEKA® Project is to Teach
- Status
- UNKNOWN
- Phase
- N/A
Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients
- Status
- UNKNOWN
- Phase
- N/A
Prone Positioning on Admission for Hospitalized COVID-19 Pneumonia Protocol
- Status
- UNKNOWN
- Phase
- NA
Saliva as Source of Detection for SARS-CoV-2
- Status
- COMPLETED
- Phase
- N/A
Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning
- Status
- COMPLETED
- Phase
- NA
Implications of Covid-19 on the Lifestyle Changes
- Status
- COMPLETED
- Phase
- N/A
Tocilizumab in Coronavirus-19 Positive Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection
- Status
- TERMINATED
- Phase
- N/A
The Safety & Efficacy of Imatinib for the Treatment of SARS-COV-2 Induced Pneumonia
- Status
- UNKNOWN
- Phase
- PHASE3
Data Analysis of the Cytokine Adsorption Treatment on Coronavirus Disease-19 (COVID-19) Patients With Respiratory Failure
- Status
- WITHDRAWN
- Phase
- N/A